Douglas J. Gentilcore
SVP, Danyelza Bus. Unit Head · Y-mAbs Therapeutics, Inc.
Individual
- 2025
- Sep 16, 2025
- 1
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Douglas J. Gentilcore's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Eric Venker - $65.62M in ROIV purchases and sales in the last 12 months
- EcoR1 Capital, LLC - $65.00M in TRAX purchases and sales in the last 12 months
- Forbion Growth Opportunities Fund III Cooperatief U.A. - $64.80M in BRVE purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $63.45M in SEPN purchases and sales in the last 12 months
- BVF PARTNERS L P - $62.96M in MLTX purchases and sales in the last 12 months
- Mario Schlosser - $62.90M in OSCR purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Douglas J. Gentilcore?
Douglas J. Gentilcore is a corporate insider, tracked as SVP, Danyelza Bus. Unit Head of Y-mAbs Therapeutics, Inc. (YMAB). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Douglas J. Gentilcore last file a Form 4?
The only primary Form 4 on record is dated 16 September 2025.